LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
As AstraZeneca’s share price drops 13% should I buy on the dip?
Investing Articles
3 stunning FTSE 100 shares I plan to buy in October
Investing Articles
This UK stock looks pretty cheap to me
Investing Articles
My favourite UK share on the entire LSE has fallen 5% in a week! Time to buy?
Investing Articles
FTSE 100 investors should pay attention to these 4 things in September 2024
Investing Articles
4 stocks that might power the FTSE 100 towards 10,000
Investing Articles
As AstraZeneca reaches a 52-week high, is this still a top UK stock to consider?
Investing Articles
5 FTSE stocks Fools think will lead the next bull market charge
Investing Articles
Up 38% from its 12-month low, how can AstraZeneca’s share price still look cheap?
Investing Articles
AstraZeneca hits £200bn as its share price soars. Can I afford to miss out?
Investing Articles
If I had £5k to invest in August, I’d buy these 2 top FTSE 100 stocks